Common Equity: The sum of all common equity items.
Atara Biotherapeutics, Inc. (ATRA) had Common Equity of $-37.90M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$1.22M |
|
$-2.23M |
|
$0.27M |
|
$0.96M |
|
$4.19M |
|
$-2.97M |
|
$0.74M |
|
$-2.23M |
|
$-2.23M |
|
$-2.23M |
|
$-2.23M |
|
$-2.23M |
|
$-2.23M |
|
$-2.97M |
|
$-3.01M |
|
15.33M |
|
15.33M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$11.31M |
|
$0.04M |
|
$7.29M |
|
$18.61M |
|
$6.57M |
|
-- |
|
$49.94M |
|
$56.51M |
|
|
Common Equity |
$-37.90M |
$-37.90M |
|
$-37.90M |
|
10.19M |
|
| Cash Flow Statement Financials | |
$-7.29M |
|
$-5.79M |
|
$8.66M |
|
$8.48M |
|
$4.05M |
|
$-4.43M |
|
$1.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.72 |
|
-- |
|
-- |
|
-- |
|
-- |
|
78.35% |
|
-242.65% |
|
-242.65% |
|
-- |
|
-182.11% |
|
-182.11% |
|
$-7.29M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
1.77 |
|
50.81 |
|
5.88% |
|
5.88% |
|
-11.98% |
|
5.88% |
|
$-3.72 |
|
$-0.48 |
|
$-0.48 |
|